Khan M M H, Saito Shigeyuki, Takagi Satoru, Ohnishi Hirofumi, Izumi Hisako, Sakauchi Fumio, Washio Masakazu, Sonoda Tomoko, Nagata Yoshie, Asakura Sumiyo, Kobayashi Kota, Mori Mitsuru, Shimamoto Kazuaki
Department of Public Health, Sapporo Medical University School of Medicine, Japan.
Hepatogastroenterology. 2006 Sep-Oct;53(71):742-6.
BACKGROUND/AIMS: Both the incidence of diabetes mellitus (DM) and mortality from Hepatocellular carcinoma (HCC) are increasing in Japan. As the association of overall cancer and HCC with impaired glucose tolerance (IGT) has been studied rarely in the world including Japan, this study assessed their associations using cohort data of Hokkaido, Japan.
After getting ethical consent, this study included 908 men and 1,081 women aged 30-77 years during 1977-78 and collected detailed information using the baseline survey. The subjects were followed until 2002 and deaths were recorded using ICD-9. Classifying them into three groups of diabetes status namely DM, IGT, and normal, the relative risk (RR) of mortality was estimated by diabetes status using multivariate Cox model.
This study revealed no association between overall cancer and diabetes status. However, the RR of mortality from HCC was about 11 times (HR= 10.8, 95%CI: 1.3-92.5) higher in IGT compared with normal group. DM group also showed higher risk of mortality than normal group.
HCC mortality was significantly high among IGT group. However, as the results of the study were based on small data, further studies with large cohort are needed to address the association of IGT with overall cancer and HCC mortality in Japan.
背景/目的:在日本,糖尿病(DM)的发病率和肝细胞癌(HCC)的死亡率都在上升。由于包括日本在内的全球范围内,总体癌症和HCC与糖耐量受损(IGT)之间的关联研究较少,本研究使用日本北海道的队列数据评估了它们之间的关联。
在获得伦理批准后,本研究纳入了1977 - 1978年期间908名年龄在30 - 77岁之间的男性和1081名女性,并通过基线调查收集了详细信息。对这些受试者进行随访直至2002年,并使用国际疾病分类第九版(ICD - 9)记录死亡情况。将他们分为糖尿病状态的三组,即DM、IGT和正常组,使用多变量Cox模型按糖尿病状态估计死亡率的相对风险(RR)。
本研究未发现总体癌症与糖尿病状态之间存在关联。然而,与正常组相比,IGT组HCC死亡率的RR约高11倍(HR = 10.8,95%CI:1.3 - 92.5)。DM组的死亡率风险也高于正常组。
IGT组的HCC死亡率显著较高。然而,由于本研究结果基于小样本数据,需要进一步开展大样本队列研究,以探讨IGT与日本总体癌症及HCC死亡率之间的关联。